Cargando…
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive canc...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023852/ https://www.ncbi.nlm.nih.gov/pubmed/35450905 http://dx.doi.org/10.1136/bmjopen-2021-056637 |
_version_ | 1784690430316642304 |
---|---|
author | Peremiquel-Trillas, Paula Saura-Lázaro, Anna Benavente-Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez, Maria Ángeles Albasanz-Puig, Adaia Gudiol, Carlota Ramírez-Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz-Montplet, Carles Sedano, Ana Plans, Àngel Calvo-Cerrada, Beatriz Calle, Candela Clopés, Ana Carnicer-Pont, Dolors Alemany, Laia Fernández, Esteve |
author_facet | Peremiquel-Trillas, Paula Saura-Lázaro, Anna Benavente-Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez, Maria Ángeles Albasanz-Puig, Adaia Gudiol, Carlota Ramírez-Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz-Montplet, Carles Sedano, Ana Plans, Àngel Calvo-Cerrada, Beatriz Calle, Candela Clopés, Ana Carnicer-Pont, Dolors Alemany, Laia Fernández, Esteve |
author_sort | Peremiquel-Trillas, Paula |
collection | PubMed |
description | OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020–26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d’Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25–p75: 34.8–51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d’Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental. |
format | Online Article Text |
id | pubmed-9023852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-90238522022-04-22 COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain Peremiquel-Trillas, Paula Saura-Lázaro, Anna Benavente-Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez, Maria Ángeles Albasanz-Puig, Adaia Gudiol, Carlota Ramírez-Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz-Montplet, Carles Sedano, Ana Plans, Àngel Calvo-Cerrada, Beatriz Calle, Candela Clopés, Ana Carnicer-Pont, Dolors Alemany, Laia Fernández, Esteve BMJ Open Epidemiology OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020–26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d’Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25–p75: 34.8–51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d’Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental. BMJ Publishing Group 2022-04-21 /pmc/articles/PMC9023852/ /pubmed/35450905 http://dx.doi.org/10.1136/bmjopen-2021-056637 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Peremiquel-Trillas, Paula Saura-Lázaro, Anna Benavente-Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez, Maria Ángeles Albasanz-Puig, Adaia Gudiol, Carlota Ramírez-Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz-Montplet, Carles Sedano, Ana Plans, Àngel Calvo-Cerrada, Beatriz Calle, Candela Clopés, Ana Carnicer-Pont, Dolors Alemany, Laia Fernández, Esteve COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title_full | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title_fullStr | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title_full_unstemmed | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title_short | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
title_sort | covid-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in catalonia, spain |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023852/ https://www.ncbi.nlm.nih.gov/pubmed/35450905 http://dx.doi.org/10.1136/bmjopen-2021-056637 |
work_keys_str_mv | AT peremiqueltrillaspaula covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT sauralazaroanna covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT benaventemorenoyolanda covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT casabonnedelphine covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT loureiroeva covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT cabrerasandra covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT duranangela covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT garrotelidia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT braoimmaculada covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT trelisjordi covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT galanmaica covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT solerfrancesc covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT juliajoaquim covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT cortasadolca covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT dominguezmariaangeles covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT albasanzpuigadaia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT gudiolcarlota covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT ramireztarruelladolors covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT muniesajoan covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT rivasjuanpedro covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT munozmontpletcarles covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT sedanoana covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT plansangel covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT calvocerradabeatriz covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT callecandela covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT clopesana covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT carnicerpontdolors covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT alemanylaia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain AT fernandezesteve covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain |